Clinical Research in Cardiology

, Volume 101, Issue 3, pp 201–208 | Cite as

Real-world experience of drug-eluting stents in saphenous vein grafts compared to native coronary arteries: results from the prospective multicenter German DES.DE registry

  • Ibrahim Akin
  • Marcus Wiemer
  • Steffen Schneider
  • Jochen Senges
  • Matthias Hochadel
  • Gert Richardt
  • Mohamed Abdel-Wahab
  • Karl-Heinz Kuck
  • Christoph A. Nienaber
Original Paper

Abstract

Background

Bypass-graft intervention was associated with worse outcomes in the bare-metal stent era. Without sufficiently powered data from subgroup analyses, and in absence of randomized controlled trials targeting clinical endpoints, controversy is ongoing over safety and efficacy of drug-eluting stents (DES) in saphenous vein graft (SVG) lesions.

Methods and results

Between October 2005 and October 2006, 5,183 patients receiving DES in SVG (n = 251) or native coronary arteries (NCA) (n = 4,932) were enrolled at 98 DES.DE sites. The composite of death, myocardial infarction (MI), and stroke defined as major adverse cardiac and cerebrovascular events (MACCE) and target-vessel revascularization (TVR) were defined as primary endpoints. Baseline clinical and descriptive morphology of coronary artery disease revealed more severe lesions and comorbidities in the SVG group. At 1-year follow-up, the SVG group suffered from higher rates of overall death (6.6 vs. 2.5%; p < 0.0001), myocardial infarction (5.9 vs. 2.2%; p < 0.0001), MACCE (13.6 vs. 5.4%; p < 0.0001), TVR (17.7 vs. 10.4%; p < 0.001) and overall stent thrombosis (10.0 vs. 3.7%; p < 0.0001).

Conclusion

Data collected in DES.DE revealed that first generation DES used in SVG lesions did not offset the worse clinical outcomes of bypass-graft intervention. Such sobering results in SVG may suggest to opt for native vessel PCI preferentially or occasionally for surgical reintervention as decided by the Heart Team.

Keywords

Drug-eluting stent Saphenous vein graft Stent thrombosis Registry Coronary artery disease 

Notes

Conflict of interest

No conflict of interest.

References

  1. 1.
    Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW, Davis K, Killip T, Passamani E, Norris R (1994) Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomized trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 344:563–570PubMedCrossRefGoogle Scholar
  2. 2.
    Izzat MB, West RR, Bryan AJ, Angelini GD (1994) Coronary artery bypass surgery: current practice in the United Kingdom. Br Heart J 71:382–385PubMedCrossRefGoogle Scholar
  3. 3.
    Kaneko Y, Schlechta B, Steinberger W, Agstner I, Wolner E, Mohl W (2002) The impact of graft selection on outcome of coronary bypass surgery and influence of surgical experience. Heart Views 3:3Google Scholar
  4. 4.
    Raja SG, Haider Z, Ahmad M, Zaman H (2004) Saphenous vein grafts: to use or not to use? Heart Lung Circ 13:150–156PubMedCrossRefGoogle Scholar
  5. 5.
    Eagle KA, Guyton RA, Davidoff R, Edwards FH, Ewy GA, Gardner TJ, Hart JC, Hermann HC, Hillis LD, Hutter AM Jr, Ltle BW, Marlow RA, Nugent WC, Orszulak TA, American College of Cardiology; American Heart Association (2004) ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 110:e340–e437PubMedCrossRefGoogle Scholar
  6. 6.
    Fitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton JR (1996) Coronary bypass graft fate and patient outcome: angiographic follow-up of 5, 065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol 28:616–626PubMedCrossRefGoogle Scholar
  7. 7.
    Weintraub WS, Jones EL, Craver JM, Guyton RA (1994) Frequency of repeat coronary bypass or coronary angioplasty after coronary artery bypass surgery using saphenous venous grafts. Am J Cardiol 73:103–112PubMedCrossRefGoogle Scholar
  8. 8.
    European Association for Percutaneous Cardiovascular Interventions; Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D; ESC Committee for Practice Guidelines, Vahanian A, Auricchio A, Bax J, Ceconi C, Dean V, Fillippatos G, Funck-Brentano C, Hobbs R, Kearney P, McDonagh T, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Verdas PE, Widimsky P; EACTS Clinical Guidelines Committee, Kolh P, Alfieri O, Dunning J, Elia S, Kappetein P, Lockowandt U, Sarris G, Vouhe P, Kearney P, von Segesser L, Agawall S, Aladashvilli A, Alexopoulos D, Antunes MJ, Atalar E, Brutel de la Riviere A, Doganov A, Aha J, Fajadet J, Ferreira R, Garot J, Halcox J, Hasin Y, Janssens S, Kervinen K, Laufer G, Legrand V, Nashef SA, Neumann FJ, Niemela K, Nihoyannopoulos P, Noc M, Piek JJ, Rozenman Y, Sabate M, Starc R, Thielmann M, Wheatley DJ, WIndecker S, Zembala M (2010) Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Hart J 31:2501–2555Google Scholar
  9. 9.
    Cameron A, Kemp HG, Green GE (1988) Reoperation for coronary artery disease: 10 years of clinical follow-up. Circulation 78:1158–1162Google Scholar
  10. 10.
    de Jaegere PP, van Domburg RT, Feyter PJ, Ruygrok PN, van der Giessen WJ, van den Brand MJ, Serruys PW (1996) Long-term clinical outcome after stent implantation in saphenous vein grafts. J Am Coll Cardiol 28:89–96PubMedCrossRefGoogle Scholar
  11. 11.
    Savage MP, Douglas JS Jr, Fischman DL, Pepine CJ, King SB 3rd, Werner JA, Bailey SR, Overlie PA, Fenton SH, Brinker JA, Leon MB, Goldberg S (1997) Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenus Vein De Novo Trial Investigators. N Engl J Med 337:740–747PubMedCrossRefGoogle Scholar
  12. 12.
    Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE, SIRIUS Investigators (2003) Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349:1315–1323PubMedCrossRefGoogle Scholar
  13. 13.
    Stone GW, Ellis SG, Cox DA, Hermiller J, O’Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME, TAXUS-IV Investigators (2004) One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV Trial. Circulation 109:1942–1947PubMedCrossRefGoogle Scholar
  14. 14.
    Akin I, Bufe A, Schneider S, Reinecke H, Eckardt L, Richardt G, Burska D, Senges J, Kuck KH, Nienaber CA (2010) Clinical outcomes in diabetic and non-diabetic patients with drug-eluting stents: results from the first phase of the prospective multicenter German DES.DE registry. Clin Res Cardiol 99:393–400PubMedCrossRefGoogle Scholar
  15. 15.
    Dibra A, Tiroch K, Schulz S, Kelbaek H, Spaulding C, Laarman GJ, Valgimigli M, Di Lorenzo E, Kaiser C, Tierala I, Mehilli J, Campo G, Thuesen L, Vink MA, Schalij MJ, Schömig A, Kastrati A (2010) Drug-eluting stent in acute myocardial infarction: updated meta-analysis of randomized trials. Clin Res Cardiol 99:345–357PubMedCrossRefGoogle Scholar
  16. 16.
    Hoffmann R, Klinker H, Adamu Ul Kelm M, Blindt R (2009) The risk of definite stent thrombosis is increased after “off-label” stent implantation irrespective of drug-eluting stent or bare-metal stent use. Clin Res Cardiol 98(9):549–554PubMedCrossRefGoogle Scholar
  17. 17.
    Bauer T, Nienaber CA, Akin I, Kuck KH, Hochadel M, Senges J, Fetsch T, Tebbe U, Willich SN, Stumpf J, Sabin GV, Silber S, Richardt G, Zanh R, for the DES.DE Study Group (2011) Comparison between on-label versus off-label use of drug-eluting coronary stents in clinical practice: results from the German DES.DE registry. Clin Res Cardiol 100:701–709PubMedCrossRefGoogle Scholar
  18. 18.
    Zahn R, Hamm CW, Schneider S, Zeymer U, Richardt G, Kelm M, Levenson B, Bonzel T, Tebbe U, Sabin G, Nienaber CA, Pfannebecker J, Senges J, German Cypher Stent Registry (2007) The sirolimus-eluting coronary stent in daily practice in Germany: trends in indications over the years: results from the prospective multicenter German Cypher Stent Registry. Clin Res Cardiol 96(8):548–556PubMedCrossRefGoogle Scholar
  19. 19.
    Nienaber CA, Akin I, Schneider S, Senges J, Fetsch T, Tebbe U, Willich SN, Stumpf J, Sabin GV, Silber S, Richardt G, Kuck KH, DES.DE Study Group (2009) Clinical outcome after sirolimus-eluting, paclitaxel-eluting, and bare-metal stents (from the first phase of prospective multicenter German DES.DE registry. Am J Cardiol 104:1362–1369PubMedCrossRefGoogle Scholar
  20. 20.
    Silber S, Albertsson P, Avilés FF, Camici PG, Colombo A, Hamm C, Jørgensen E, Marco J, Nordrehaug JE, Ruzyllo W, Urban P, Stone GW, Wijns W, Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology (2005) Guidelines for Percutaneous Coronary Intervention: the task force for percutaneous coronary interventions of the European society of cardiology. Eur Heart J 26:804–847PubMedCrossRefGoogle Scholar
  21. 21.
    Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van ES GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW, Academic Research Consortium (2007) Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115:2344–2351PubMedCrossRefGoogle Scholar
  22. 22.
    Keeley EC, Grines CL (1998) Scraping of aortic debris by coronary guiding catheters: a prospective evaluation of 1,000 cases. J Am Coll Cardiol 32:1861–1865PubMedCrossRefGoogle Scholar
  23. 23.
    Mauri L, Cox D, Hermiller J, Massaro J, Wahr J, Tay SW, Jonas M, Popma JJ, Wahr D, Rogers C (2007) The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Praxis Embolic Protection System: A randomized prospective, multicenter clinical trial. J Am Coll Cardiol 50:1442–1449PubMedCrossRefGoogle Scholar
  24. 24.
    Brilakis ES, Lichtenwalter C, de Lemos JA, Roesle M, Obel O, Haagen D, Saeed B, Gadiparthi C, Bissett JK, Sachdeva R, Vourris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger P, Baerjee S (2009) A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous graft lesions. The SOS (Stenting Of Saphenous Vein Grafts) Trial. J Am Coll Cardiol 53:919–928PubMedCrossRefGoogle Scholar
  25. 25.
    Vermeersch P, Agostoni P, Verheye S, Van den Heuvel P, Convens C, Bruining N, Van den Branden F, Van Langenhove G (2006) Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial. J Am Coll Cardiol 48:2423–2431PubMedCrossRefGoogle Scholar
  26. 26.
    Vermeersch P, Agostoni P, Verheye S, Van den Heuvel P, Convens C, Van den Branden F, Van Langenhove G, DELAYED RRISC (Death and Events at Long-term follow-up AnalYsis: Extended Duration of the Reduction of Restenosis In Saphenous vein grafts with Cypher stent) Investigators (2007) Increased late mortality after sirolimus-eluting sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC trial. J Am Coll Cardiol 50:261–267PubMedCrossRefGoogle Scholar
  27. 27.
    Hoffmann R, Hamm C, Nienaber CA, Levenson B, Bonzel T, Sabin G, Senges J, Zahn R, Tebbe U, Pfannebecker T, Richardt HG, Schneider S, Kelm M, for the German Cypher Registry (2007) Implantation of sirolimus-eluting stents in saphenous vein grafts is associated with higher clinical follow-up event rates compared with treatment of native vessels. Coron Artery Dis 18:559–564PubMedCrossRefGoogle Scholar
  28. 28.
    Vignali L, Saia F, Manari A, Santarelli A, Rubboli A, Varani E, Piovaccari G, Menozzi A, Percoco G, Benassi A, Rusticali G, Marzaroli P, Guastaroba P, Grilli R, Maresta A, Marzocchi A (2008) Long-term outcomes with drug-eluting stents versus bare metal stents in the treatment of saphenous vein graft disease (results from the REgistro Regionale AngiopLastiche Emillial-Romagna Registry). Am J Cardiol 101:947–952PubMedCrossRefGoogle Scholar
  29. 29.
    Brodie BR, VerSteeg DS, Brodie MM, Hansen C, Richter SJ, Stuckey TD, Gupta N, Pulsipher M, Downey W (2005) Poor long-term patient and graft survival after primary percutaneous coronary intervention for acute myocardial infarction due to saphenous vein graft occlusion. Catheter Cardiovasc Interv 65:504–509PubMedCrossRefGoogle Scholar
  30. 30.
    Lins M, Heuer M, Braun P, Franz N, Simon R, FIRST Trial Investigators (2007) Distal embolic protection during percutaneous intervention of aorto-coronary venous bypass grafts: the FIRST Trial. Clin Res Cardiol 96(10):738–742PubMedCrossRefGoogle Scholar
  31. 31.
    Kalan JM, Roberts WC (1990) Morphologic findings in saphenous veins used as coronary arterial bypass conduits for longer than 1 year: necropsy analysis of 53 patients, 123 saphenous veins, and 1865 five-millimeter segments. Am Heart J 119:1164–1184PubMedCrossRefGoogle Scholar
  32. 32.
    Mathew V, Berger PB, Lennon RJ, Gersh BJ, Holmes DR Jr (2000) Comparison of percutaneous interventions for unstable angina pectoris in patients with and without previous coronary artery bypass grafting. Am J Cardiol 86:931–937PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Ibrahim Akin
    • 1
  • Marcus Wiemer
    • 2
  • Steffen Schneider
    • 3
  • Jochen Senges
    • 3
  • Matthias Hochadel
    • 3
  • Gert Richardt
    • 4
  • Mohamed Abdel-Wahab
    • 4
  • Karl-Heinz Kuck
    • 5
  • Christoph A. Nienaber
    • 1
  1. 1.Divisions of Cardiology, Pulmology and Intensive Care Medicine, Department of Internal Medicine I, Heart Center RostockUniversity Hospital Rostock, Rostock School of MedicineRostockGermany
  2. 2.Department of CardiologyHeart Center Bad OeynhausenBad OeynhausenGermany
  3. 3.Department of CardiologyHeart Center Ludwigshafen/IKKF LudwigshafenLudwigshafenGermany
  4. 4.Department of CardiologyHeart Center Bad SegebergBad SegebergGermany
  5. 5.Department of CardiologyAsklepios Hospital HamburgHamburgGermany

Personalised recommendations